Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 11, Issue 3, 1998, Pages 153-173

  Laube, Beth L ^a   Benedict, G William ^b   Dobs, Adrian S ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioavailability; Deposition; Diabetes; Nebulized insulin

Indexed keywords

INSULIN;

AEROSOL; BIOAVAILABILITY; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INSULIN BLOOD LEVEL; NEBULIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; REGRESSION ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031791013     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1998.11.153     Document Type: Conference Paper

References (28)

1. Harris, M.I. 1995. Diabetes in America, ed 2. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NEH Publication No 95-1468, Bethesda, MD.
2. Moses, A.C., G.S. Gordon, M.C. Carey, and J.S. Flier. 1983. Insulin administered intranasally as an insulin-bile salt aerosol: Effectiveness and reproducibility in normal and diabetic subjects. Diabetes. 32:1040-1047.
3. Salzman, R., J.E. Manson, and G.T. Griffing. 1985. Intranasal aerosolized insulin. N. Engl. J. Med. 312:1078-1084.
4. Mygind, N. 1985. Upper airway: Structure, function and therapy. In F. Moren, M.T. Newhouse, and M.B. Dolovich, eds. Aerosols in Medicine. Principles, Diagnosis and Therapy. Elsevier Science Publishers. New York, 1-20.
5. Weibel, E.R. 1964. Morphometrics of the lung. In W.O. Ferm, and H. Rahn, eds. Handbook of Physiology, Section 3, Respiration. American Physiological Society, Washington, DC, 284-307.
6. Byron, P.R. 1986. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J. Pharm. Sci. 75:433-438.
7. DeFouw, D. 1983. Ultrastructural features of alveolar epithelial transport. Am. Rev. Respir. Dis. 127 (suppl):S9-S13.
8. Gil, J. Number and distribution of plasmalemmal vesicles in the lung. 1983. Fed. Proc. 42:2414-2418.
9. Cresia, D.A., G.A. Saviolakis, and H.A. Bostian. 1988. Efficacy of inhaled insulin: Effect of adjuvant [abstract] FASEB J. 2:A537.
10. Almer, L-O., A. Troedsson, M. Arborelius, Jr, P. Wellmer, B. Jenson, K. Backstrom, and M. Dahlback. 1988. Insulin inhalation-at last a breakthrough. Diabetes Res. Clin. Pract. 5 (suppl):S163.
11. Jendle, J.H., B.E. Karlberg, and M. Arborelius, Jr. 1996. An exploration of intrapulmonary insulin administration in anaesthetised and mechanically ventilated pigs. Scan. J. Clin. Lab. Invest. 56:251-258.
12. Gaensslen, M. 1925. Uber inhalation von insulin. Klin. Wochenschrift. 2:71-72.
13. Wigley, F.M., J.H. Londono, S.H. Wood, J.C. Shipp, and R.H. Waldman. 1971. Insulin across respiratory mucosae by aerosol delivery. Diabetes. 20:552-556.
14. Heinemann, T., T. Traut, and T. Heise. 1997. Time-action profile of inhaled insulin. Diabetic Medicine 14:63-72.
15. Elliott, R.B., B.W. Edgar, C.C. Pilcher, C. Quested, and J. McMaster. 1987. Parenteral absorption of insulin from the lung in diabetic children. Aust. Paediatr. J. 23:293-297.
16. Jendle, J.H., and B.E. Karlberg. 1996. Intrapulmonary administration of insulin to healthy volunteers. J. Intern. Med. 240:93-98.
17. Kohler, D., K.J. Schluter, L. Kerp, and H. Matthys. 1987. Nicht radioaktives verfahren zur messung der lungenpermeabilitat: inhalation von insulin. Atemv. Lungenkrkh. 13:230-232.
18. Laube, B.L., A. Georgopoulos, and G.K. Adams III. 1993. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA. 269:2106-2109.
19. Jendle, J.H., and B.E. Karlberg. 1996. Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes. Scan. J. Clin. Lab. Invest. 56:555-561.
20. Galloway, J.A., C.T. Spradlin, R.L. Nelson, S.M. Wentworth, J.A. Davidson, and J.L. Swarner. 1981. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care. 3:366-376.
21. Adjei, A.L., R. Doyle, M. Pratt, R. Finley, and E. Johnson. 1990. Bioavailability of leuprolide following intratracheal administration to Beagle dogs. Int. J. Pharm. 61:135-144.
22. Colthorpe, P., S.J. Farr, G. Taylor, I.J. Smith, and D. Wyatt. 1992. The pharmacokinetics of pulmonary delivered insulin: A comparison of intratracheal and aerosol administration to the rabbit. Pharm. Res. 9:764-768.
23. Francis, A.J., I. Hanning, and K.G.M.M. Alberti. 1985. The influence of insulin antibody levels on plasma profiles and action of subcutaneously injected human and bovine short-acting insulins. Diabetologia. 28:330-334.
24. Macey, D.J., and R. Marshall. 1982. Absolute quantitation of radiotracer uptake in the lungs using gamma camera. J. Nucl. Med. 23:731-735.
25. Patton, J.S., and R.M. Platz. 1994. Aerosol insulin-a brief review. In P. Byron, R. Dalby, and S. Farr eds. Respiratory Drug Delivery IV. Interpharm Press, Buffalo Grove, IL, 65-74.
26. Laube, B.L., D.L. Swift, H.N. Wagner, P.S. Norman, and G.K. Adams III. 1986. The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma. Am. Rev. Respir. Dis. 133:740-743.
27. Dolovich, M.D., J. Sanchis, C. Rossman, and M.T. Newhouse. 1976. Aerosol penetrance: A sensitive index of peripheral airways obstruction. J. Appl. Physiol. 40:468-471.
28. Chung, K.F., P.D. Snashall, and K. Jeyasingh. 1988. Influence of airway calibre on the interpulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur. Respir. J. 1:890-895.